HEPATOBLAST_RESEC

Description: |
Stores data for College of American Pathologists (CAP) form 76023-HEPATOBLASTOMA (PEDIATRIC LIVER): Resection.

Primary Key

Column Name | Ordinal Position |
--- | --- | ---
RESULT_ID | 1 |

Column Information

| Name | Type | Discontinued? |
--- | --- | --- | --- | ---
1 | RESULT_ID | VARCHAR | No |
The unique identifier for the result record.
2 | OTHER_CLIN_FNDGS | VARCHAR | No |
CAP synoptic form item: Other Clinical Findings.
3 | TUMOR_SITE_SPECIFY | VARCHAR | No |
CAP synoptic form item: Specify tumor site.
4 | CAP_COMMENTS | VARCHAR | No |
CAP synoptic form item: General comments.
5 | SPEC_PROC_SPECIFY | VARCHAR | No |
CAP synoptic form item: Specify the Specimen Procedure.
6 | TUMOR_SIZE_GREAT | NUMERIC | No |
CAP synoptic form item: Tumor Greatest Size.
7 | TUMOR_SIZE_ADDL | NUMERIC | No |
CAP synoptic form item: Tumor Size (length).
8 | TUMOR_SIZE_ADDL2 | NUMERIC | No |
CAP synoptic form item: Tumor Size (width).
9 | TUMOR_SIZE_SPECIFY | VARCHAR | No |
CAP synoptic form item: Specify Tumor Size.
10 | HISTO_TYPE_SPECIFY | VARCHAR | No |
CAP synoptic form item: Specify histologic type.
11 | MARGIN_UNITS_C_NAME | VARCHAR | No |
CAP synoptic form item: Margin Units.
May contain organization-specific values: Yes
Category Entries:
mm
cm
12 | RESECTION_MARGIN_C_NAME | VARCHAR | No |
CAP synoptic form item: Resection Margin.
May contain organization-specific values: Yes
Category Entries:
Cannot be assessed
Uninvolved by invasive tumor
Involved by invasive tumor
13 | HISTOLOGIC_GRADE_C_NAME | VARCHAR | No |
CAP synoptic form item: Histologic Grade.
May contain organization-specific values: Yes
Category Entries:
Not applicable
GX: Cannot be assessed
G1: Well differentiated
G2: Moderately differentiated
G3: Poorly differentiated
G4: Undifferentiated
G4: Undifferentiated / anaplastic
WHO grade not assigned
Low-grade (well-differentiated to moderately differentiated)
High-grade (poorly differentiated to undifferentiated)
FIGO Grade 1
FIGO Grade 2
FIGO Grade 3
Favorable (purely epithelial, fetal subtype, mitotically inactive with <=2 mitoses in
Less favorable (all subtypes other than those designated "Favorable" or "Unfavorable"
Unfavorable (small cell undifferentiated or rhabdoid as the predominant or sole histo
Gleason Pattern
Ungraded sarcoma
pGX: Grade cannot be assessed
pG1: Spindle cell melanoma
pG2: Mixed cell melanoma
pG3: Epithelioid cell melanoma
WHO Grade I
WHO Grade II
WHO Grade III
WHO Grade IV
pG1: Well differentiated
pG2: Moderately differentiated
pG3: Poorly differentiated
pG4: Undifferentiated
FNCLCC Grade 1
FNCLCC Grade 2
FNCLCC Grade 3
Grade 1
Grade 2
Grade 3
Cannot be determined
Other
14 | PERCENT_HIST_FEATUR | NUMERIC | No |
CAP synoptic form item: Percentage of Tumor with this Histologic Feature.
15 | HEPATOBLASTOMA_SPFY | VARCHAR | No |
CAP synoptic form item: Specify Hepatoblastoma.
16 | MACRO_EXTENT_SPFY | VARCHAR | No |
CAP synoptic form item: Specify Macroscopic Extent.
17 | RESEC_MRG_SPFY | VARCHAR | No |
CAP synoptic form item: Specify Resection Margin.
18 | DIST_INV_TMR_MRG | NUMERIC | No |
CAP synoptic form item: Distance of Invasive Tumor from Closest Margin.
19 | CAPSULAR_SURFACE_C_NAME | VARCHAR | No |
CAP synoptic form item: Capsular Surface.
The category values for this column were already listed for column: RESECTION_MARGIN_C_NAME
20 | SURFACE_MARGIN_SPFY | VARCHAR | No |
CAP synoptic form item: Specify Surface Margin.
21 | DIST_TMR_SURFACE | NUMERIC | No |
CAP synoptic form item: Distance of Invasive Tumor from Closest Surface.
22 | MARGIN_UNITS_2_C_NAME | VARCHAR | No |
CAP synoptic form item: Margin Units (second measurement).
The category values for this column were already listed for column: MARGIN_UNITS_C_NAME
23 | LYM_ND_METASTASIS_C_NAME | VARCHAR | No |
CAP synoptic form item: Lymph Node Metastasis.
May contain organization-specific values: Yes
Category Entries:
pNX: Cannot be assessed
pN0: No regional lymph node metastasis
pN1: Regional lymph node metastasis
pN1: Metastasis in perirectal lymph nodes
pN1: Metastasis in 1 to 3 regional lymph nodes
pN1a: Metastasis in 1 regional lymph node
pN1b: Metastasis in 2 to 3 regional lymph nodes
pN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirecta
pN1 (IIIC1): Regional lymph node metastasis to pelvic lymph nodes
pN1: Regional lymph node metastasis involving 1 to 2 nodes
pN1 (IIIC): Regional lymph node metastasis
pN1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery
pN1: Metastasis in single ipsilateral lymph node, 3 cm or less in greatest dimension
pN1: Metastasis in ipsilateral peribronchial and / or ipsilateral hilar lymph nodes,
pN1: Metastases in the ipsilateral bronchopulmonary or hilar lymph nodes
pN1a: Clinically occult (microscopic) metastasis
pN1b: Clinically apparent (macroscopic) metastasis
pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension
pN1: Metastasis in a single regional lymph node, 2 cm or less in greatest dimension
pN1: Metastasis in 1 to 2 perigastric lymph nodes
pN1: Metastasis with a lymph node mass less than 2 cm in greatest dimension,
pN1a: Nodal metastases to Level VI lymph nodes
pN1b: Metastases to unilateral, bilateral or contralateral cervical
pN1: Single regional lymph node metastasis in the true pelvis
pN1 (IVB): Pelvic or inguinal lymph node metastasis
pN1: Metastasis in regional lymph node or nodes
pN1: Regional lymph node involvement (preauricular, cervical, submandibular)
pN2: Metastasis in unilateral internal iliac and / or inguinal lymph node(s)
pN2: Metastasis in 4 or more regional lymph nodes
pN2: Metastasis to periaortic/pericaval/super. mesentery artery/celiac artery lym nd
pN2a: Metastasis in 4 to 6 regional lymph nodes
pN2b: Metastasis in 7 or more regional lymph nodes
pN2 (IIIC2): Regional lymph node metastasis to para-aortic lymph nodes, with or witho
pN2: 3 to 6 nodes involved
pN2: Metastases to periaortic,pericaval,super. mesenteric artery, celiac artery lym n
pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm
pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than
pN2b: Metastasis in a single ipsilateral lymph nodes, none >6cm in greatest dimension
pN2b: Metastasis in multiple ipsilateral lymph nodes, none >6cm in greatest dimension
pN2c: Metastasis in bilateral/contralateral lymph nodes, none >6cm in greatest dimen.
pN2: Metastasis in ipsilateral mediastinal and / or subcarinal lymph node(s)
pN2: Metastases in the subcarinal or the ipsilateral mediastinal lymph nodes
pN2a: Clinically occult (microscopic) metastasis
pN2b: Clinically apparent (macroscopic) metastasis
pN2c: Satellite or in-transit metastasis without nodal metastasis
pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension
pN2: Metastasis in a single regional lymph node, more than 2 cm but not more than
pN2: Metastasis in 3 to 6 perigastric lymph nodes
pN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm
pN2: Multiple regional lymph node metastasis in the true pelvis
pN2: Distant lymph node involvement
pN3: Metastasis in perirectal and inguinal lymph nodes and / or bilateral internal il
pN3: 7 or more nodes involved
pN3: Metastasis in a lymph node more than 6 cm in greatest dimension
pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or
pN3: Metastases in the contralateral mediastinal, contralateral internal mammary,
pN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or
pN3: Metastasis in a lymph node greater than 6 cm and / or to supraclavicular fossa
pN3a: Greater than 6 cm in dimension
pN3b: Extension to the supraclavicular fossa
pN3: Metastasis in a regional lymph node more than 5 cm in greatest dimension
pN3: Metastasis in 7 or more perigastric lymph nodes
pN3a: Metastasis in 7 to 15 perigastric lymph nodes
pN3b: Metastasis in 16 or more perigastric lymph nodes
pN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension
pN3: Lymph node metastasis to the common iliac lymph nodes
pN1: One or two regional lymph nodes with the following features
pN2 (FIGO IIIB): Regional lymph node metastasis with the following features
pN3 (FIGO IVA): Fixed or ulcerated regional lymph node metastasis
24 | LYM_ND_METAS_LOC | VARCHAR | No |
CAP synoptic form item: Lymph Node Metastasis Location.
25 | LYM_ND_METAS_EXAM | NUMERIC | No |
CAP synoptic form item: Lymph Node Metastasis Nodes Examined.
26 | LYM_ND_METAS_INVOLV | NUMERIC | No |
CAP synoptic form item: Lymph Node Metastasis Nodes Involved by Tumor.
27 | SPECIAL_STD_SPFY | VARCHAR | No |
CAP synoptic form item: Specify Special Studies.
28 | ADDL_PATH_HEPATITIS | VARCHAR | No |
CAP synoptic form item: Additional Pathologic Findings Hepatitis.
29 | ADDL_PATH_FIND_SPFY | VARCHAR | No |
CAP synoptic form item: Specify additional pathologic findings.
30 | DISTNT_METASTASIS_C_NAME | VARCHAR | No |
CAP synoptic form item: Distant Metastasis.
May contain organization-specific values: Yes
Category Entries:
Not applicable
cM0 (i+): No clinical or radiographic evidence of distant metastasis
pM0: No distant metastasis
pM1: Distant metastasis
pM1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyx
pM1b: Nonperitoneal metastasis
pM1: Distant detectable metastasis as determined by classic clinical
pM1 (IVB): Distant metastasis
pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or
pM1b: Distant metastases outside the lung / pleura
pM1: Distant metastasis (documented in this specimen)
pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes
pM1b: Metastasis to lung
pM1c: Metastasis to all other visceral sites or distant metastasis at any site
pM1a: Nonregional lymph node(s)
pM1b: Bone(s)
pM1c: Other site(s) with or without bone disease
pM1: Metastasis to sites other than CNS
pM1a: Single lesion
pM1b: Multiple lesions
pM1c: CNS metastasis
pM1d: Discrete mass(es) without leptomeningeal and / or CSF involvement
pM1e: Leptomeningeal and / or CSF involvement
pM1a: Non-regional lymph nodes or pulmonary metastasis
pM1b: Distant metastasis other than to nonregional lymph nodes and lungs
pM1a (III): Tumor extends to the lungs with or without genital tract involvement
pM1b (IV): Tumor involves other metastatic sites
pM1a: Largest diameter of the largest metastasis 3 cm or less
pM1b: Largest diameter of the largest metastasis 3.1-8.0 cm
pM1c: Largest diameter of the largest metastasis 8 cm or more
pM1a: Lung
pM1b: Metastasis involving distant sites other than lung (including skip metastases)
Distant Metastasis present (includes metastasis to lymph nodes)
31 | DSTNT_METASTATIS_ST | VARCHAR | No |
CAP synoptic form item: Distant Metastasis Sites.